Corrigendum: Cost-effectiveness of avelumab maintenance therapy plus best supportive care vs. best supportive care alone for advanced or metastatic urothelial carcinoma

Detalles Bibliográficos
Autores principales: Xie, Qian, Zheng, Hanrui, Chen, Ye, Peng, Xingchen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360972/
https://www.ncbi.nlm.nih.gov/pubmed/35958843
http://dx.doi.org/10.3389/fpubh.2022.965798
_version_ 1784764427597250560
author Xie, Qian
Zheng, Hanrui
Chen, Ye
Peng, Xingchen
author_facet Xie, Qian
Zheng, Hanrui
Chen, Ye
Peng, Xingchen
author_sort Xie, Qian
collection PubMed
description
format Online
Article
Text
id pubmed-9360972
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93609722022-08-10 Corrigendum: Cost-effectiveness of avelumab maintenance therapy plus best supportive care vs. best supportive care alone for advanced or metastatic urothelial carcinoma Xie, Qian Zheng, Hanrui Chen, Ye Peng, Xingchen Front Public Health Public Health Frontiers Media S.A. 2022-07-26 /pmc/articles/PMC9360972/ /pubmed/35958843 http://dx.doi.org/10.3389/fpubh.2022.965798 Text en Copyright © 2022 Xie, Zheng, Chen and Peng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Xie, Qian
Zheng, Hanrui
Chen, Ye
Peng, Xingchen
Corrigendum: Cost-effectiveness of avelumab maintenance therapy plus best supportive care vs. best supportive care alone for advanced or metastatic urothelial carcinoma
title Corrigendum: Cost-effectiveness of avelumab maintenance therapy plus best supportive care vs. best supportive care alone for advanced or metastatic urothelial carcinoma
title_full Corrigendum: Cost-effectiveness of avelumab maintenance therapy plus best supportive care vs. best supportive care alone for advanced or metastatic urothelial carcinoma
title_fullStr Corrigendum: Cost-effectiveness of avelumab maintenance therapy plus best supportive care vs. best supportive care alone for advanced or metastatic urothelial carcinoma
title_full_unstemmed Corrigendum: Cost-effectiveness of avelumab maintenance therapy plus best supportive care vs. best supportive care alone for advanced or metastatic urothelial carcinoma
title_short Corrigendum: Cost-effectiveness of avelumab maintenance therapy plus best supportive care vs. best supportive care alone for advanced or metastatic urothelial carcinoma
title_sort corrigendum: cost-effectiveness of avelumab maintenance therapy plus best supportive care vs. best supportive care alone for advanced or metastatic urothelial carcinoma
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360972/
https://www.ncbi.nlm.nih.gov/pubmed/35958843
http://dx.doi.org/10.3389/fpubh.2022.965798
work_keys_str_mv AT xieqian corrigendumcosteffectivenessofavelumabmaintenancetherapyplusbestsupportivecarevsbestsupportivecarealoneforadvancedormetastaticurothelialcarcinoma
AT zhenghanrui corrigendumcosteffectivenessofavelumabmaintenancetherapyplusbestsupportivecarevsbestsupportivecarealoneforadvancedormetastaticurothelialcarcinoma
AT chenye corrigendumcosteffectivenessofavelumabmaintenancetherapyplusbestsupportivecarevsbestsupportivecarealoneforadvancedormetastaticurothelialcarcinoma
AT pengxingchen corrigendumcosteffectivenessofavelumabmaintenancetherapyplusbestsupportivecarevsbestsupportivecarealoneforadvancedormetastaticurothelialcarcinoma

Ejemplares similares